Trial Profile
Ambispective Observational Post-Authorisation Study on the Use of Bemfola in Human Assisted Reproductive Techniques in Spain.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2020
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Acronyms BIRTH
- Sponsors Finox Biotech
- 04 Feb 2020 Status changed from recruiting to completed.
- 06 Feb 2018 Planned end date changed from 1 Oct 2017 to 1 Oct 2018.
- 06 Feb 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.